Detalhe da pesquisa
1.
The network of non-coding RNAs and their molecular targets in breast cancer.
Mol Cancer
; 19(1): 61, 2020 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32188472
2.
MiR-16-1-3p and miR-16-2-3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma.
Int J Cancer
; 145(11): 3052-3063, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018244
3.
Loss of miR-204 expression is a key event in melanoma.
Mol Cancer
; 17(1): 71, 2018 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29523154
4.
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants.
Amino Acids
; 50(3-4): 421-438, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29313085
5.
Blood to skin recirculation of CD4+ memory T cells associates with cutaneous and systemic manifestations of psoriatic disease.
Clin Immunol
; 180: 84-94, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28392462
6.
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
PLoS Genet
; 9(3): e1003311, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23505378
7.
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.
Proc Natl Acad Sci U S A
; 109(8): 3024-9, 2012 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315424
8.
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eµ-miR-155 transgenic mouse model.
Proc Natl Acad Sci U S A
; 109(49): 20047-52, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169640
9.
Reprogramming of miRNA networks in cancer and leukemia.
Genome Res
; 20(5): 589-99, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20439436
10.
GAMES identifies and annotates mutations in next-generation sequencing projects.
Bioinformatics
; 27(1): 9-13, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20971986
11.
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling.
Front Endocrinol (Lausanne)
; 13: 834075, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35282462
12.
Identification of microRNA activity by Targets' Reverse EXpression.
Bioinformatics
; 26(1): 91-7, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19897564
13.
UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines.
Genes (Basel)
; 12(12)2021 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34946928
14.
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis.
Prog Neurobiol
; 190: 101803, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335272
15.
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.
Front Genet
; 9: 174, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29868122
16.
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.
Mol Ther Nucleic Acids
; 13: 334-346, 2018 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30340138
17.
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts.
Biomark Res
; 6: 31, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30450210
18.
An Ultraconserved Element Containing lncRNA Preserves Transcriptional Dynamics and Maintains ESC Self-Renewal.
Stem Cell Reports
; 10(3): 1102-1114, 2018 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29456181
19.
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.
Oncotarget
; 9(34): 23543-23553, 2018 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29805754
20.
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.
Cancer Cytopathol
; 125(8): 635-643, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28449331